Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 24,254 shares at an average $11.20 ($271,680)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Regulation FD disclosure · Other events
  18. 8-K Event Shareholder vote results · Other events
  19. 425 Deal Prospectus/Communication re Business Combination
  20. 10-Q Report Quarterly Report

Page 14 of 33 · 660 filings